Recent analyses on retatruded, a dual activator for incretin hormone and glucose-dependent insulinotropic polypeptide, demonstrate significant results in treating excess body fat and type 2 diabetic condition. Preliminary information from clinical trials point to notable reductions in body weight and enhanced glucose control. Additional examinat… Read More